Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
IAXO-102 is a glycolipid and an antagonist of toll-like receptor 4 (TLR4).1 It inhibits lipid A-induced TLR4 activation in a cell-based assay (IC50 = 5.013 µM). IAXO-102 (10 mg/kg) reduces LPS-induced lethality in mice. It decreases angiotensin II-induced aortic expansion and rupture, as well as the incidence of abdominal aortic aneurysms, in ApoE-/- mice when administered at a dose of 3 mg/kg.2
WARNING This product is not for human or veterinary use.
1. Glycolipids and benzylammonium lipids as novel antisepsis agents: Synthesis and biological characterization. J. Med. Chem. 52(4), 1209-1213 (2009).
2. A novel small molecule TLR4 antagonist (IAXO-